Early Enteral Feeding in Postsurgical Cancer Patients
- 1 March 1996
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 223 (3) , 316-333
- https://doi.org/10.1097/00000658-199603000-00013
Abstract
The authors compared the safety, gastrointestinal tolerance, and clinical efficacy of feeding an enteral diet containing a fish oil/medium-chain triglyceride structured lipid (FOSL-HN) versus an isonitrogenous, isocaloric formula (O-HN) in patients undergoing major abdominal surgery for upper gastrointestinal malignancies. Previous studies suggest that feeding with n-3 fatty acids from fish oil can alter eicosanoid and cytokine production, yielding an improved immunocompetence and a reduced inflammatory response to injury. The use of n-3 fatty acids as a structured lipid can improve long-chain fatty acid absorption. This prospective, blinded, randomized trial was conducted in 50 adult patients who were jejunally fed either FOSL-HN or O-HN for 7 days. Serum chemistries, hematology, urinalysis, gastrointestinal complications, liver and renal function, plasma and erythrocyte fatty acid analysis, urinary prostaglandins, and outcome parameters were measured at baseline and on day 7. Comparisons were made in 18 and 17 evaluable patients based a priori on the ability to reach a tube feeding rate of 40 mL/hour. Patients receiving FOSL-HN experienced no untoward side effects, significant incorporation of eicosapentaenoic acid into plasma and erythrocyte phospholipids, and a 50% decline in the total number of gastrointestinal complications and infections compared with patients given O-HN. The data strongly suggest improved liver and renal function during the postoperative period in the FOSL-HN group. Early enteral feeding with FOSL-HN was safe and well tolerated. Results suggest that the use of such a formula during the postoperative period may reduce the number of infections and gastrointestinal complications per patient, as well as improve renal and liver function through modulation of urinary prostaglandin levels. Additional clinical trials to fully quantify clinical benefits and optimize nutritional support with FOSL-HN should be undertaken.Keywords
This publication has 43 references indexed in Scilit:
- Effect of Dietary Fish Oil on Renal Function and Rejection in Cyclosporine-Treated Recipients of Renal TransplantsNew England Journal of Medicine, 1993
- The Effect of Increasing Levels of Fish Oil‐Containing Structured Triglycerides on Protein Metabolism in Parenterally Fed Rats Stressed by Burn Plus EndotoxinJournal of Parenteral and Enteral Nutrition, 1993
- Changes in Plasma and Erythrocyte Fatty Acids in Patients Fed Enteral Formulas Containing Different FatsJournal of Parenteral and Enteral Nutrition, 1993
- The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.Journal of Clinical Investigation, 1990
- Administration of Structured Lipid Composed of MCT and Fish Oil Reduces Net Protein Catabolism in Enterally Fed Burned RatsAnnals of Surgery, 1989
- The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear CellsNew England Journal of Medicine, 1989
- The effect of route of nutrient administration on the nutritional state, catabolic hormone secretion, and gut mucosal integrity after burn injuryJournal of Parenteral and Enteral Nutrition, 1987
- Effect of a Fish-Oil-Supplemented Diet on Inflammation and Immunological Processes in RatsInternational Archives of Allergy and Immunology, 1987
- Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine, 1985
- Linoleic Acid Absorption from Lipid Supplements in Patients with Cystic Fibrosis with Pancreatic Insufficiency and in Control SubjectsJournal of Pediatric Gastroenterology and Nutrition, 1985